Early-Onset Neutropenia Induced by Rituximab in a Patient with Lupus Nephritis and Hemolytic Anemia

Figure 1

Hemoglobin, neutrophil count, and platelet count during hospitalization. Marked decreases in neutrophils and platelets are observed after seven days of the second rituximab infusion. Hemoglobin levels increased eight days after the second rituximab infusion and remained stable throughout hospitalization. Cell count returned to normal levels twelve days after the final rituximab dose. After four years of follow-up, hemoglobin, neutrophil count, and platelet count remained normal.